GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a major focus in healthcare studies, largely due to its impressive impact on managing ailments such as type 2 diabetes and weight gain. Ongoing research have revealed that in addition to glucose management, GLP-1 agonists offer potential for cardiovascular well-being an